SuperSonic Imagine
Private Company
Total funding raised: $28M
Overview
SuperSonic Imagine is a pioneer in ultrasound imaging, known for its proprietary ShearWave Elastography technology, which provides quantitative tissue stiffness measurements in real-time. The company targets the global diagnostic imaging market with systems used in radiology, obstetrics/gynecology, and other clinical specialties. As a historically public company that faced financial challenges, it was acquired by Hologic, Inc. in 2021, integrating its technology into a larger portfolio. Its core value proposition lies in enhancing diagnostic capabilities beyond conventional anatomical ultrasound.
Technology Platform
UltraFast ultrasound imaging platform enabling real-time, quantitative ShearWave Elastography to map tissue stiffness.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Operates in the highly competitive diagnostic ultrasound market dominated by GE Healthcare, Philips, Siemens Healthineers, and Canon Medical, all of whom have developed their own elastography technologies. Competes with other specialized elastography devices, such as FibroScan for liver assessment. Differentiation relies on the quantitative accuracy, real-time capability, and large-field-of-view of its proprietary ShearWave technology.